To evaluate the efficacy, safety and tolerability of Hilterapia® (High Intensity Laser Therapy) in the chronic articular inflammatory processes in haemophilic adult patients
Not Applicable
Completed
- Conditions
- HaemophiliaHaematological Disorders
- Registration Number
- ISRCTN02847428
- Lead Sponsor
- Baxter (Italy)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
1. Adult subjects with haemophilia A of any severity with or not suppressant
2. Age more than or equal to 18 years
3. Subjects who have been previously diagnosed with a chronic articular inflammatory process or hematoma
4. Subjects who have signed an informed written consent
Exclusion Criteria
Subjects with under way bleeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Pain will be measured using the Visual Analogue Scale (VAS) score (0 = no pain, 10 = unbearable pain) at baseline (T1), T4, T7 and T10 visits <br>2. Nieschl?s Score and the articular state will be measured using Hemophilia Joint Health Score 2.0
- Secondary Outcome Measures
Name Time Method o secondary outcome measures